Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.032x

Based on the latest financial reports, Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) has a cash flow conversion efficiency ratio of 0.032x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥88.11 Million ≈ $12.89 Million USD) by net assets (CN¥2.73 Billion ≈ $399.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300357 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shanghai DaZhong Public Utilities Group Co Ltd SHG:600635	0.022x
Crystal Growth & Energy Equipment Co. Ltd. A SHG:688478	N/A
Greatech Technology Bhd KLSE:0208	0.011x
Sichuan Furong Technology Co Ltd SHG:603327	-0.013x
Dime Community Bancshares, Inc. NASDAQ:DCOM	0.032x
Foreign Trade Bank of Latin America Inc NYSE:BLX	0.838x
Compania Nationala de Transport al Energiei Electrice Transelectrica SA RO:TEL	0.054x
Jiangsu Provincial Agricultural Reclamation and Development Co Ltd SHG:601952	0.011x

Annual Cash Flow Conversion Efficiency for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (2009–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.46 Billion ≈ $359.80 Million	CN¥262.44 Million ≈ $38.40 Million	0.107x	-36.68%
2023-12-31	CN¥2.30 Billion ≈ $337.10 Million	CN¥388.32 Million ≈ $56.82 Million	0.169x	-5.16%
2022-12-31	CN¥2.03 Billion ≈ $296.63 Million	CN¥360.28 Million ≈ $52.72 Million	0.178x	-11.44%
2021-12-31	CN¥1.80 Billion ≈ $262.90 Million	CN¥360.58 Million ≈ $52.76 Million	0.201x	+19.70%
2020-12-31	CN¥1.53 Billion ≈ $223.62 Million	CN¥256.22 Million ≈ $37.49 Million	0.168x	-2.68%
2019-12-31	CN¥1.35 Billion ≈ $197.83 Million	CN¥232.93 Million ≈ $34.08 Million	0.172x	-16.93%
2018-12-31	CN¥995.42 Million ≈ $145.66 Million	CN¥206.45 Million ≈ $30.21 Million	0.207x	+4.43%
2017-12-31	CN¥801.26 Million ≈ $117.25 Million	CN¥159.13 Million ≈ $23.29 Million	0.199x	+6.05%
2016-12-31	CN¥655.58 Million ≈ $95.93 Million	CN¥122.77 Million ≈ $17.97 Million	0.187x	-4.93%
2015-12-31	CN¥582.91 Million ≈ $85.30 Million	CN¥114.82 Million ≈ $16.80 Million	0.197x	+20.85%
2014-12-31	CN¥513.55 Million ≈ $75.15 Million	CN¥83.70 Million ≈ $12.25 Million	0.163x	-29.58%
2013-12-31	CN¥251.92 Million ≈ $36.86 Million	CN¥58.30 Million ≈ $8.53 Million	0.231x	+1.97%
2012-12-31	CN¥181.38 Million ≈ $26.54 Million	CN¥41.17 Million ≈ $6.02 Million	0.227x	+51.24%
2011-12-31	CN¥127.61 Million ≈ $18.67 Million	CN¥19.15 Million ≈ $2.80 Million	0.150x	-6.64%
2010-12-31	CN¥90.44 Million ≈ $13.23 Million	CN¥14.54 Million ≈ $2.13 Million	0.161x	+42.42%
2009-12-31	CN¥111.89 Million ≈ $16.37 Million	CN¥12.63 Million ≈ $1.85 Million	0.113x	--

About Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

SHE:300357 China Drug Manufacturers - General

Market Cap

$1.63 Billion

CN¥11.13 Billion CNY

Market Cap Rank

#7048 Global

#1600 in China

Share Price

CN¥21.25

Change (1 day)

+1.53%

52-Week Range

CN¥19.91 - CN¥35.30

All Time High

CN¥5101.55